Effects of LDL Lipids on Activity of Group IIA Secretory Phospholipase A2

被引:3
|
作者
Samoilova, E. V. [1 ]
Pirkova, A. A. [1 ]
Prokazova, N. V. [1 ]
Korotaeva, A. A. [1 ]
机构
[1] Fed Agcy Hlth Care & Social Dev, Moscow, Russia
基金
俄罗斯基础研究基金会;
关键词
secretory phospholipase A2; oxidized phosphatidylcholin; sphyngomyelin; cholesterol; cholesterol esters; A(2); INHIBITION;
D O I
10.1007/s10517-010-1062-5
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Effects of phosphatidylcholine, oxidized phosphatidylcholine, sphyngomyelin, cholesterol, and cholesterol esters incorporated in LDL on activity of group IIA secretory phospholipase A2 from human cardiac myxoma were studied. Liposomes containing radioisotope-labeled phosphatidylethanolamine served as the substrate for group IIA secretory phospholipase A2. Oxidized phosphatidylcholine significantly stimulated activity of group IIA secretory phospholipase A2, while phosphatidylcholine in the same concentrations did not modify enzyme activity. Sphyngomyelin incorporated in LDL inhibited group IIA secretory phospholipase A2 activity. Cholesterol and cholesterol esters virtually did not modify enzyme activity. The results indicate that LDL phospholipids and their oxidized forms can be involved in regulation of group IIA secretory phospholipase A2. Study of the mechanisms regulating the proinflammatory group IIA secretory phospholipase A2 can promote the development of new approaches to the diagnosis and treatment of inflammatory processes.
引用
收藏
页码:39 / 41
页数:3
相关论文
共 50 条
  • [21] Antifibrotic activity of an inhibitor of group IIA secretory phospholipase A2 in young spontaneously hypertensive rats
    Levick, Scott
    Loch, David
    Rolfe, Barbara
    Reid, Robert C.
    Fairlie, David P.
    Taylor, Stephen M.
    Brown, Lindsay
    JOURNAL OF IMMUNOLOGY, 2006, 176 (11): : 7000 - 7007
  • [22] Gastroduodenal reflux induces group IIa secretory phospholipase A2 expression and activity in murine esophagus
    Mauchley, David
    Meng, Xianzhong
    Babu, Ashok
    Gamboni-Robertson, Fabia
    Yang, Xiaoping
    Banerjee, Anirban
    Fullerton, David A.
    Weyant, Michael J.
    DISEASES OF THE ESOPHAGUS, 2010, 23 (05) : 430 - 436
  • [23] Mildly oxidized LDL induces expression of group IIa secretory phospholipase A2 in human monocyte-derived macrophages
    Anthonsen, MW
    Stengel, D
    Hourton, D
    Ninio, E
    Johansen, B
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (05) : 1276 - 1282
  • [24] Group IIa secretory phospholipase A2 (sPLA2IIa) and progression in patients with lung cancer
    Wang, M.
    Hao, F-Y.
    Wang, J-G.
    Xiao, W.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (18) : 2648 - 2654
  • [25] Role of oxidized phosphatidyl choline in oxidized LDL-induced activation of proinflammatory secretory phospholipase A2 group IIA
    Samoylova, Elena
    Korotaeva, Aleksandra
    Piksina, Galina
    Prokazova, Nina
    INFLAMMATION RESEARCH, 2010, 59 : S50 - S50
  • [26] Inhibitory effect of exendin-4 on secretory group IIA phospholipase A2
    Lee, Wonhwa
    Kwak, Soyoung
    Lee, Hyun-Shik
    Na, Dong Hee
    Lee, You-Mie
    Bae, Jong-Sup
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 459 (04) : 650 - 654
  • [27] Inhibitory effect of baicalin, baicalein and wogonin on secretory group IIA phospholipase A2
    Sae-Kwang Ku
    Hyun Gyu Lee
    Jong-Sup Bae
    Archives of Pharmacal Research, 2015, 38 : 1865 - 1872
  • [28] Inhibitory effect of baicalin, baicalein and wogonin on secretory group IIA phospholipase A2
    Ku, Sae-Kwang
    Lee, Hyun Gyu
    Bae, Jong-Sup
    ARCHIVES OF PHARMACAL RESEARCH, 2015, 38 (10) : 1865 - 1872
  • [29] Deterioration of axotomy-induced neurodegeneration by group IIA secretory phospholipase A2
    Yagami, T
    Ueda, K
    Asakura, K
    Hori, Y
    BRAIN RESEARCH, 2001, 917 (02) : 230 - 234
  • [30] Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade
    Graff, JR
    Konicek, BW
    Deddens, JA
    Chedid, M
    Hurst, BM
    Colligan, B
    Neubauer, BL
    Carter, HW
    Carter, JH
    CLINICAL CANCER RESEARCH, 2001, 7 (12) : 3857 - 3861